AP
Atwood & Palmer’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8M | Sell |
41,588
-386
| -0.9% | -$203K | 1.36% | 32 |
|
|
2025
Q1 | $26.6M | Sell |
41,974
-1,709
| -4% | -$1.08M | 1.85% | 22 |
|
|
2024
Q4 | $31.1M | Sell |
43,683
-117
| -0.3% | -$83.3K | 2.13% | 17 |
|
|
2024
Q3 | $46M | Sell |
43,800
-59
| -0.1% | -$62K | 3.13% | 3 |
|
|
2024
Q2 | $46.1M | Sell |
43,859
-79
| -0.2% | -$83K | 3.49% | 1 |
|
|
2024
Q1 | $42.3M | Sell |
43,938
-536
| -1% | -$516K | 3.21% | 1 |
|
|
2023
Q4 | $39.1M | Sell |
44,474
-851
| -2% | -$747K | 3.16% | 3 |
|
|
2023
Q3 | $37.3M | Sell |
45,325
-150
| -0.3% | -$123K | 3.27% | 1 |
|
|
2023
Q2 | $32.7M | Buy |
45,475
+3,393
| +8% | +$2.44M | 2.92% | 5 |
|
|
2023
Q1 | $34.6M | Buy |
42,082
+90
| +0.2% | +$74K | 3.25% | 3 |
|
|
2022
Q4 | $30.3M | Buy |
41,992
+81
| +0.2% | +$58.4K | 2.74% | 7 |
|
|
2022
Q3 | $28.9M | Buy |
41,911
+429
| +1% | +$296K | 2.86% | 7 |
|
|
2022
Q2 | $24.5M | Buy |
41,482
+431
| +1% | +$255K | 2.39% | 11 |
|
|
2022
Q1 | $28.7M | Buy |
41,051
+295
| +0.7% | +$206K | 2.48% | 13 |
|
|
2021
Q4 | $25.7M | Buy |
40,756
+12,454
| +44% | +$7.86M | 2.15% | 17 |
|
|
2021
Q3 | $17.1M | Buy |
28,302
+126
| +0.4% | +$76.3K | 1.53% | 29 |
|
|
2021
Q2 | $15.7M | Buy |
28,176
+28,026
| +18,684% | +$15.7M | 1.41% | 31 |
|
|
2021
Q1 | $71K | Buy |
150
+50
| +50% | +$23.7K | 0.01% | 199 |
|
|
2020
Q4 | $48K | Buy |
100
+25
| +33% | +$12K | 0.01% | 213 |
|
|
2020
Q3 | $42K | Buy |
+75
| New | +$42K | 0.01% | 204 |
|